The United States Patent and Trademark Office (USPTO) has issued patent US12582356B2, titled 'Intravascular devices, systems, and methods,' to Philips Image Guided Therapy Corporation. The patent, which has an effective date of March 24, 2026, and was filed on November 4, 2024, details innovations in intravascular devices. Specifically, it describes devices incorporating electronic, optical, or electro-optical components within their distal portions, along with specialized connectors, such as flexible coils, which may be embedded in polymer tubing. The patent also covers methods for manufacturing and assembling these devices.

This patent grant represents a new intellectual property right for the assignee, Philips Image Guided Therapy Corporation, concerning medical device technology. While patent grants are not regulatory rules imposing direct compliance obligations on other entities, they establish exclusive rights that can impact market competition and innovation. Companies operating in the intravascular device sector, particularly those developing similar technologies, should be aware of this patent to avoid potential infringement claims. No immediate compliance actions are required for other entities, but legal counsel should be consulted regarding freedom to operate and potential licensing needs.